Our recent activity
Asabys Partners da entrada al FEI y eleva su primer fondo a 117 millones
Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
READ THIS NEWS IN SPANISH Proceeds used to complete ongoing ATHENA pivotal IDE study, continue product development, and secure global regulatory approvals for neurovascular portfolio Anaconda Biomed, a medical technology…
iPremom raises €15m to transform pregnancy care with molecular diagnostics
iPremom raises €15m to transform pregnancy care with molecular diagnostics
READ THIS NEWS IN SPANISH iPremom, a molecular diagnostics company dedicated to the earliest prediction of pregnancy complications, has raised €15m in seed funding led by Amadeus Capital Partners, co-led…
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline
READ THIS NEWS IN SPANISH Oriva is developing innovative medicines for chronic gynaecological diseases and is backed by pre-seed financing from Asabys Partners’ Sabadell Asabys II fund Dr Arbat brings…